Japan Echocardiography Market - Strategic Insights and Forecasts (2026-2031)

Japan Echocardiography Market is projected to register a strong CAGR during the forecast period (2026-2031).

The rising incidence of cardiovascular diseases, the growing preference for non-invasive diagnostic imaging, and the ongoing technological improvements of ultrasound are the primary factors driving the consistent growth of the Japanese echocardiography market. Echocardiography is an extensively utilized imaging method that uses ultrasound waves to create live images of the heart. As a result, doctors can evaluate the cardiac anatomy, the circulation of blood, and the functioning of the heart.

• The rising overall challenge of diseases, including heart failure, coronary artery disease, and congenital heart defects in Japan, has considerably raised the necessity for precise and timely diagnostic methods, hence pushing the usage of echocardiography systems in healthcare facilities and diagnostic centers.

• There are approximately 1.2 million people in Japan suffering from heart failure (HF). The number of patients with HF is growing alongside the aging population of Japan, and it is projected that the figure will be more than 1.3 million by 2030.

• Echocardiography is increasingly being used in emergency care, intensive care units, and point-of-care diagnostics, thus significantly driving its demand. On the other hand, expensive equipment and the necessity for trained experts to interpret the images might limit the market expansion.

• Government health initiatives promote the early diagnosis and proper management of cardiovascular conditions, thereby growing the use of diagnostic imaging instruments, including echocardiography.

• Ministry of Health, Labour and Welfare has been running different programs like Specific Health Checkups and Specific Health Guidance to help with the early detection of cardiovascular diseases and to facilitate the use of advanced diagnostic technologies like echocardiography among medical institutions in Japan.

• Japan's parliament approved a budget totalling ¥115.5 trillion for the 2025 administration year, representing a 2.6% rise compared to the previous year.

• Social security expenditure accounted for a third of the overall amount and increased by 1.5% to ¥38.3 trillion, financing healthcare requirements of the elderly population, along with initiatives to mitigate the falling birth rate.

• The market is growing as more people are using advanced technologies such as 3D and 4D echocardiography, Doppler imaging, and portable ultrasound devices that not only improve the accuracy of diagnostics but also help in point-of-care testing.

• Moreover, the rising elderly population and greater consciousness about early detection of heart diseases are consequently driving the demand for echocardiography procedures in Japan.

• Japan's Ministry of Internal Affairs and Communications reported that in 2024, the nation had 36.25 million elderly people aged 65 and above, marking the highest number in history and representing 29.3% of the total population. This percentage is expected to increase to 34.8% by 2040 and 36.3% by 2045.

• Improved healthcare infrastructure, growing healthcare spending, and supportive government initiatives focused on improving cardiac care are some of the factors contributing to further strengthening the market growth.

• Japan has a hospital bed availability of 12.5 beds per 1, 000 population. This is significantly more than the OECD average of 4.2.

• Japan has a relatively high number of diagnostic imaging machines, namely CT scanners, MRI units, and PET scanners, 184 units per million people, whereas the OECD average is just 51.

• The continuous innovation and the rising emphasis on preventive cardiac diagnostics will offer large opportunities for the Japanese echocardiography market in the future.

Market Dynamics

Drivers

• Rising Prevalence of Lifestyle-Related Heart Diseases

The increasing number of heart diseases related to lifestyle is majorly pushing up the need for echocardiography in Japan. Alterations in lifestyle, like lesser physical exercise, higher work stress, unhealthy diet, and smoking, have led to the increased occurrence of cardiovascular diseases like hypertension, coronary artery disease, and cardiomyopathy. In Japan, 51% of adults did not have sufficient physical activity, a figure higher than the OECD average of 30%.

• Besides, metabolic disorders, including obesity and diabetes, have been spreading, hence increasing the likelihood of heart problems among people.

• The International Diabetes Federation (IDF) ranks Japan among the top ten countries with the largest number of adults (aged 20-79 years) suffering from diabetes worldwide.

• The number of adults (20-79 years) living with diabetes in Japan (JP) was 10.8 million in 2024. The figure is forecasted to reach 9.4 million by 2050.

• Since healthcare providers in Japan are focusing more on preventive care and regular cardiovascular screening, the requirement for echocardiography procedures will continue to grow.

• The Paradise Ultrasound Renal Denervation (RDN) system was launched in Japan in 2026, and it is covered by the national insurance.

• The ultrasound-based device is a new technology that features a focused ultrasound beam. It is used to control the resistant arterial nerves in hypertension, which produce abnormally high blood pressure.

• It reflects the increasing uptake of ultrasound-guided cardiovascular treatments in Japan.

Key Developments

• November 2025: FUJIFILM Sonosite, Inc., a player in the field of point-of-care ultrasound solutions, has revealed the introduction of Sonosite MT, which is an upgraded version of its portable ultrasound systems.

• August 2025: GE^[1] HealthCare launched Vivid Pioneer, its next-generation cardiovascular ultrasound system. It integrates advanced AI capabilities to enhance workflow speed, precision, and image quality for specialized echocardiography examinations.

• August 2025: Philips^[2] introduced the Transcend Plus premium edition for its EPIQ CVx and Affiniti CVx systems, deploying AI-enabled clinical applications and enhanced 3D echocardiography image processing capabilities.

• January 2024: Canon, a player in imaging devices, has introduced the Aplio me in Japan, a shared-service ultrasound system that can address the wide range of needs of regular users in different clinical settings.

Market Segmentation

By Type: Stress Echocardiography

Based on type, the Japanese echocardiography market is divided into transthoracic echocardiography, transesophageal echocardiography, stress echocardiography, fetal echocardiography, and others, where the transthoracic echocardiography accounts for a significant share in 2026. Likewise, the transesophageal echocardiography and stress echocardiography are set to grow at a considerable rate during the forecasted timeframe, while fetal echocardiography and others are expected to hold a substantial market share in the coming years.

The Japanese echocardiography market for stress echocardiography is expected to grow at a healthy rate over the forecast period. The stress echocardiography segment is one of the fastest-growing segments in the market, which is driven by diverse factors. Primarily, the segment is witnessing growth due to the country's rising super-aged demographic, along with an increase in the burden of cardiovascular diseases, which creates the necessity for non-invasive stress-testing and point-of-care cardiac imaging systems across the region.

• According to the Statistics Bureau of Japan, the country's population aged 65 and over is expected to report a robust growth from 29.3 percent, which is 36.25 million of the total population in 2024, to 30.8 % in 2030 and further to 32.2 percent in 2035, and 36.3 percent by 2045, which promotes the need for non-invasive cardiac imaging devices.

• Further, this aging demographic pressure accelerated the requirement for minimal-disruptive diagnostic procedures such as stress echocardiography that offer support for patients in outpatient and rehabilitation settings without the need for invasive procedures or prolonged hospital stays.

• Additionally, the nation’s growing prevalence of coronary artery diseases, cardiac arrest, stroke, and other cardiovascular diseases, which is accelerating due to an aging population and changing lifestyle factors, increases the demand for stress echocardiography.

• Moreover, the domestic market players such as Canon Medical System, Fujifilm Holding Corporation, and Philips Healthcare are increasingly adopting AI-enabled 3D/4D imaging along with connectivity features for enhancing the diagnostic accuracy in their stress echocardiography.

By Device Type: Handheld/ Portable Devices

By device type, the Japanese echocardiography market is divided into cart-based echocardiography and handheld/ portable echocardiography, where the former accounts for a considerable market share in 2031 and will grow at a considerable rate. Similarly, handheld/ portable devices are set to grow steadily during the forecasted timeframe.

High prevalence of heart disease in Japan, followed by a growing elderly population, which accounts for nearly 30% of the total population as per the World Bank, has made the population more vulnerable to such health concern has accelerated demand for POC (Point-of-Care) solutions in hospitals and emergency centers.

• Moreover, favorable government initiatives like implementing the “Stroke and Cardiovascular Disease Control Act” and the “Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease Control Act” further raised the requirement for non-invasive cardiac monitoring.

• With technological advancement gaining traction in the Japanese medical sector, the transition towards miniaturized ultrasound and imaging devices equipped with AI-assisted features is picking up pace. Foreign players, namely Butterfly Network Inc., have formed strategic tie-ups with Japan-based Southwood Inc. to integrate the latter’s AI for echocardiography with the former’s portable ultrasound diagnostics devices like “Butterfly iQ3”.

• Ongoing shift towards minimally invasive diagnostics, followed by post-pandemic transition towards decentralized care, has bolstered portable devices development for echocardiography. Additionally, the ongoing healthcare innovation outlines the consumer preference for cost-effective miniaturized devices for echocardiography.

List of Companies

• Fujifilm Holdings Corporation

• Canon Medical Systems

• Koninklijke Philips N.V.

• Siemens

• Esaote S.p.A

• Nihon Kohden Corporation

• General Electric Company

• Butterfly Network Inc.

Fujifilm Holdings Corporation is a Japan-based multinational founded in 1934 and headquartered in Tokyo. The company operates across healthcare, electronics, imaging, and business innovation segments, leveraging core technologies in optics, imaging, electronics, and chemical processing. Fujifilm develops diagnostic imaging systems, medical IT platforms, and life-science solutions that enable clinical diagnosis and treatment. The medical systems portfolio of the company contains CT, MRI, ultrasound, digital radiography, endoscopy, and enterprise imaging software, which enhances workflow efficiency and clinical decision-making.

Fujifilm operates in the Japanese echocardiography market through its cardiovascular ultrasound systems and AI-enabled imaging platforms, which create detailed cardiac images for diagnosing heart diseases. The company’s echocardiography solutions combine high-resolution ultrasound hardware with software platforms that include AI-assisted analysis and enterprise imaging systems.

Japan Echocardiography Market Scope: